China’s health regulator gave conditional approval to Platinum Life Excellence Biotech Co. Ltd.’s amimestrocel injection (hUC ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...

Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced ...

Hyderabad: A group of postgraduate students from Loyola Academy in Alwal visited Professor Jayashankar Telangana Agricultural ...

EBBH-2024 is under clinical development by Essen Biotech and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL).

Company Making Additions to Executive Team and Advisory Board to Support Significant Commercial MomentumLONDON, Jan. 09, 2025 (GLOBE NEWSWIRE) -- (Ori), a leader in cell and gene therapy (CGT) ...

The biotech company requested a trading halt before the market open on Friday. Here's why. The post Why are Mesoblast shares ...

A 62-year-old Verulam resident was attacked by two men with okapi knives in the area's CBD this morning, hours before he ...

A new year is the perfect time to make sure you've got the best cell phone plan for your needs — and if you don't, it's time to consider your options for getting more data at a lower monthly cost.

Mr. Kalir brings a wealth of experience as an investor, entrepreneur, and thought leader with a deep focus on life sciences and technology. Currently the Managing Member of Martial Eagle Fund and a ...

Tumor Infiltrating Lymphocytes (TIL) is under clinical development by Essen Biotech and currently in Phase II for Metastatic Breast Cancer.